---
title: "Medtronic: Undervalued But Underperforming - Why Innovation Isn't Enough To Lift The Stock"
date: "2025-02-07 04:19:06"
summary: "Klaus Vedfelt Introduction My last analysis of Medtronic (NYSE:MDT) acknowledged that, while the company appears modestly undervalued in a discounted cash flow model, its slow growth will likely result in continued stock underperformance. Since my \"sell\" rating in October, MDT is up 2.37%, underperforming S&amp;P 500"
categories:
  - "seekalpha_articles"
lang:
  - "en"
translations:
  - "en"
tags:
  - "seekalpha_articles"
menu: ""
thumbnail: "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1227305760/image_1227305760.jpg"
lead: ""
comments: false
authorbox: false
pager: true
toc: false
mathjax: false
sidebar: "right"
widgets:
  - "search"
  - "recent"
  - "taglist"
---

![Man and woman carrying large orange bar graph](https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1227305760/image_1227305760.jpg?io=getty-c-w750) 



Klaus Vedfelt



Introduction
------------

My [last analysis](https://seekingalpha.com/article/4731293-medtronic-undervalued-but-trapped-in-slow-growth-mdt-stock "https://seekingalpha.com/article/4731293-medtronic-undervalued-but-trapped-in-slow-growth-mdt-stock") of **Medtronic** (NYSE:[MDT](https://seekingalpha.com/symbol/MDT "Medtronic plc")) acknowledged that, while the company appears modestly undervalued in a discounted cash flow model, its slow growth will likely result in continued stock underperformance. Since my "sell" rating in October, MDT is up 2.37%, underperforming S&P 500

[seekalpha_articles](https://seekingalpha.com/article/4755853-medtronic-undervalued-underperforming-innovation-not-enough-to-lift-stock)
